FFA
TECH icon

Frazier Financial Advisors’s Bio-Techne TECH Stock Holding History

Frazier Financial Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-52
Closed -$2.72K – 830
2026
Q1 		$2.72K Hold
52
– – ﹤0.01% 554
2025
Q4 		$3.06K Hold
52
– – ﹤0.01% 520
2025
Q3 		$2.89K Hold
52
– – ﹤0.01% 500
2025
Q2 		$2.68K Hold
52
– – ﹤0.01% 508
2025
Q1 		$3.05K Hold
52
– – ﹤0.01% 480
2024
Q4 		$3.76K Hold
52
– – ﹤0.01% 475
2024
Q3 		$4.16K Hold
52
– – ﹤0.01% 563
2024
Q2 		$3.73K Hold
52
– – ﹤0.01% 684
2024
Q1 		$3.66K Hold
52
– – ﹤0.01% 657
2023
Q4 		$4.01K Buy
+52
New +$3.42K ﹤0.01% 547

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Frazier Financial Advisors's TECH Position: Q2 2026 in Review

Frazier Financial Advisors sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 52 shares — an estimated $2.72K sold.

Frazier Financial Advisors first reported a position in TECH in Q4 2023 and held it in 10 quarters. The position peaked at $4.16K in Q3 2024. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Frazier Financial Advisors reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Frazier Financial Advisors sold 52 Bio-Techne shares in Q2 2026, an estimated $2.72K.
  • Frazier Financial Advisors first reported a position in Bio-Techne in Q4 2023 and held it in 10 quarters.
  • Frazier Financial Advisors's Bio-Techne position peaked at $4.16K in Q3 2024.
  • 595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.